Cargando…
Pandemic Influenza Vaccines – The Challenges
Recent years’ enzootic spread of highly pathogenic H5N1 virus among poultry and the many lethal zoonoses in its wake has stimulated basic and applied pandemic vaccine research. The quest for an efficacious, affordable and timely accessible pandemic vaccine has been high on the agenda. When a variant...
Autores principales: | Haaheim, Lars R., Madhun, Abdullah S., Cox, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185517/ https://www.ncbi.nlm.nih.gov/pubmed/21994584 http://dx.doi.org/10.3390/v1031089 |
Ejemplares similares
-
Vaccines for an influenza pandemic: scientific and political challenges
por: Haaheim, Lars R.
Publicado: (2007) -
A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models
por: Cox, Rebecca J., et al.
Publicado: (2009) -
Influenza: the virus and prophylaxis with inactivated influenza vaccine in “at risk” groups, including COPD patients
por: Hovden, Arnt-Ove, et al.
Publicado: (2007) -
Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1–3, 2010
por: Haaheim, Lars R., et al.
Publicado: (2011) -
The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants
por: Jul-Larsen, Åsne, et al.
Publicado: (2012)